Motoji T - Search Results

1

Prognostic significance of PRAME expression based on immunohistochemistry for diffuse large B-cell lymphoma patients treated with R-CHOP therapy.

Mitsuhashi K, Masuda A, Wang YH, Shiseki M, Motoji T. Mitsuhashi K, et al. Among authors: motoji t. Int J Hematol. 2014 Jul;100(1):88-95. doi: 10.1007/s12185-014-1593-z. Epub 2014 May 13. Int J Hematol. 2014. PMID: 24820636

2

[Nasal NK-cell lymphoma].

Fukuda J, Yoshihara T, Arai Y, Kaneko T, Zheng H, Mori S, Aoyama M, Masuda M, Motoji T, Oshimi K, et al. Fukuda J, et al. Among authors: motoji t. Rinsho Ketsueki. 1994 Jun;35(6):588-92. Rinsho Ketsueki. 1994. PMID: 8078194 Japanese.

3

Recovery of drug sensitivity by MS-209, a new multidrug resistance-reversing agent, on acute myelogenous leukaemic blasts and K562 cells resistant to adriamycin cell line.

Wang YH, Motoji T, Motomura S, Shiozaki H, Tsuruo T, Mizoguchi H. Wang YH, et al. Among authors: motoji t. Eur J Haematol. 1997 Mar;58(3):186-94. doi: 10.1111/j.1600-0609.1997.tb00946.x. Eur J Haematol. 1997. PMID: 9150713

4

Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotides.

Motomura S, Motoji T, Takanashi M, Wang YH, Shiozaki H, Sugawara I, Aikawa E, Tomida A, Tsuruo T, Kanda N, Mizoguchi H. Motomura S, et al. Among authors: motoji t. Blood. 1998 May 1;91(9):3163-71. Blood. 1998. PMID: 9558371 Free article.

5

Delineation of the frequently deleted region on chromosome arm 13q in B-cell non-Hodgkin's lymphoma.

Wada M, Okamura T, Okada M, Teramura M, Masuda M, Motoji T, Mizoguchi H. Wada M, et al. Among authors: motoji t. Int J Hematol. 2000 Feb;71(2):159-66. Int J Hematol. 2000. PMID: 10745626

6

Significance of lung resistance-related protein in the clinical outcome of acute leukaemic patients with reference to P-glycoprotein.

Tsuji K, Motoji T, Sugawara I, Shiozaki H, Wang YH, Motomura S, Okada M, Yasunami T, Sano F, Takahashi M, Kawada H, Maseki N, Hoshino S, Ishida M, Mizoguchi H. Tsuji K, et al. Among authors: motoji t. Br J Haematol. 2000 Aug;110(2):370-8. doi: 10.1046/j.1365-2141.2000.02181.x. Br J Haematol. 2000. PMID: 10971394 Free article.

7

Multidrug resistance of acute leukemia and a strategy to overcome it.

Motoji T, Motomura S, Wang YH. Motoji T, et al. Int J Hematol. 2000 Dec;72(4):418-24. Int J Hematol. 2000. PMID: 11197207 Review.

8

Anti-lymphoma effect of naproxen and indomethacin in a patient with relapsed diffuse large B-cell lymphoma.

Yoshinaga K, Teramura M, Iwabe K, Kobayashi S, Masuda M, Motoji T, Mizoguchi H. Yoshinaga K, et al. Among authors: motoji t. Am J Hematol. 2001 Mar;66(3):220-3. doi: 10.1002/1096-8652(200103)66:3<220::aid-ajh1048>3.0.co;2-l. Am J Hematol. 2001. PMID: 11279630 Free article.

9

Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis.

Okutsu J, Tsunoda T, Kaneta Y, Katagiri T, Kitahara O, Zembutsu H, Yanagawa R, Miyawaki S, Kuriyama K, Kubota N, Kimura Y, Kubo K, Yagasaki F, Higa T, Taguchi H, Tobita T, Akiyama H, Takeshita A, Wang YH, Motoji T, Ohno R, Nakamura Y. Okutsu J, et al. Among authors: motoji t. Mol Cancer Ther. 2002 Oct;1(12):1035-42. Mol Cancer Ther. 2002. PMID: 12481426

10

Anti-proliferative effect of the abl tyrosine kinase inhibitor STI571 on the P-glycoprotein positive K562/ADM cell line.

Kotaki M, Motoji T, Takanashi M, Wang YH, Mizoguchi H. Kotaki M, et al. Among authors: motoji t. Cancer Lett. 2003 Sep 10;199(1):61-8. doi: 10.1016/s0304-3835(03)00338-0. Cancer Lett. 2003. PMID: 12963124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters